相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Successful Translation of Pharmacogenetics into the Clinic
Elizabeth Phillips et al.
Molecular Diagnosis & Therapy (2012)
HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
Hiroko Ikeda et al.
EPILEPSIA (2010)
Successful implementation of a national HLA-B*5701 genetic testing service in Canada
R. G. Lalonde et al.
TISSUE ANTIGENS (2010)
Drug-induced lupus erythematosus
Camilla Dalle Vedove et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2009)
Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms A Cause of Unpredictable Multiorgan Failure
Majed Eshki et al.
ARCHIVES OF DERMATOLOGY (2009)
Viral connection between drug rashes and autoimmune diseases: How autoimmune responses are generated after resolution of drug rashes
Noriko Aota et al.
AUTOIMMUNITY REVIEWS (2009)
Endothelial cell apoptosis in severe drug-induced bullous eruptions
L. Verneuil et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus
R. Pahk et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Judith A. Aberg et al.
CLINICAL INFECTIOUS DISEASES (2009)
The HLA-B/-C haplotype block contains major determinants for host control of HIV
E. Trachtenberg et al.
GENES AND IMMUNITY (2009)
The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting Drug
Yoko Kano et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
Soranun Chantarangsu et al.
PHARMACOGENETICS AND GENOMICS (2009)
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetic Association Studies in Drug-Induced Liver Injury
Ann K. Daly et al.
SEMINARS IN LIVER DISEASE (2009)
HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
Sirirat Likanonsakul et al.
AIDS Research and Therapy (2009)
HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz
Zulma G. Vitezica et al.
AIDS (2008)
A review of drug patch testing and implications for HIV clinicians
Neil H. Shear et al.
AIDS (2008)
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America
Benjamin Young et al.
AIDS (2008)
High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
Michael Saag et al.
CLINICAL INFECTIOUS DISEASES (2008)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Antiviral effects of silymarin against hepatitis C: The jury is still out
Stephen J. Polyak et al.
HEPATOLOGY (2008)
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity
Diana Chessman et al.
IMMUNITY (2008)
Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The HCP5 single-nucleotide polymorphism:: A simple screening tool for prediction of hypersensitivity reaction to abacavir
Sara Colombo et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
Wen-Hung Chung et al.
NATURE MEDICINE (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
Pharmacogenetics of aspirin-intolerant asthma
Seun-Hyun Kim et al.
PHARMACOGENOMICS (2008)
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2008)
Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)
P. Munderi et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A. Kindmark et al.
PHARMACOGENOMICS JOURNAL (2008)
Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience
Laura J. Waters et al.
AIDS (2007)
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome
M. Tohyama et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Drug hypersensitivity in HIV
Elizabeth Phillips et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
HLA- B*5701 typing:: evaluation of an allele-specific polymerase chain reaction melting assay
E. Hammond et al.
TISSUE ANTIGENS (2007)
Immune responses to abacavir in antigen-presenting cells from hypersensitive patients
Annalise M. Martin et al.
AIDS (2007)
Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population
David Zucman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
HLA-Cw8 primarily associated with hypersensitivity to nevirapine
Hiroyuki Gatanaga et al.
AIDS (2007)
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection - A randomized controlled trial
Roy M. Gulick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome
M. Seishima et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients
Roberto Littera et al.
AIDS (2006)
Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV Cohort study
A. Rauch et al.
CLINICAL INFECTIOUS DISEASES (2006)
A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome
Annalise M. Martin et al.
PHARMACOGENETICS AND GENOMICS (2006)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster
Ana Alfirevic et al.
PHARMACOGENETICS AND GENOMICS (2006)
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
Ana Alfirevic et al.
PHARMACOGENOMICS (2006)
Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation
K Komura et al.
JOURNAL OF DERMATOLOGY (2005)
Epidemiology of hypersensitivity drug reactions
ER Gomes et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Nevirapine-induced Stevens-Johnson syndrome in a mother and son
CA Liechty et al.
AIDS (2005)
Clinical and immunogenetic correlates of abacavir hypersensitivity
EJ Phillips et al.
AIDS (2005)
Cross hypersensitivity syndrome between phenytoin and carbamazepine
NM Sierra et al.
PHARMACY WORLD & SCIENCE (2005)
HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing
AM Martin et al.
TISSUE ANTIGENS (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria
SH Kim et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts
AM Martin et al.
AIDS (2005)
Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations
AR Hughes et al.
PHARMACOGENOMICS (2004)
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
E DeJesus et al.
CLINICAL INFECTIOUS DISEASES (2004)
Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand
R Abe et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir
EJ Phillips et al.
AIDS (2002)
Stevens-Johnson syndrome associated with abacavir therapy
P Bossi et al.
CLINICAL INFECTIOUS DISEASES (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Risk factor analysis of hypersensitivity reactions to abacavir
W Symonds et al.
CLINICAL THERAPEUTICS (2002)
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
A Nassif et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
S Hetherington et al.
LANCET (2002)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
Fixed drug eruption induced by trimethoprim-sulfamethoxazole:: Evidence for a link to HLA-A30 B13 Cw6 haplotype
E Özkaya-Bayazit et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
S Hetherington et al.
CLINICAL THERAPEUTICS (2001)
TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients
M Pirmohamed et al.
NEUROLOGY (2001)
Metabolic activation in drug allergies
BK Park et al.
TOXICOLOGY (2001)
Co-amoxiclav jaundice: clinical and histological features and HLA class II association
J O'Donohue et al.
GUT (2000)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
分享论文
